Getting 3.75mg of Mounjaro from a 5mg pen — what the dose actually means

The misconception: that a 5mg pen can be used like a syringe you control

The most common reason people search for '3.75mg Mounjaro from 5mg pen' is a half-dose idea borrowed from older injectable medicines, where a clinician might tell a patient to use half a vial. Mounjaro KwikPens do not work that way. They are single-strength, auto-inject devices, each pre-loaded with four fixed doses. The 5mg pen fires 5mg. There is no dial, no plunger, no partial-press option.

The 3.75mg figure makes more sense in a different context: it is half of a 7.5mg dose, or it can arise when someone is counting doses across pens during a transition week. If you want a fuller picture of what using a 3.75mg dose from a 5mg pen would actually mean in practice, that page covers the mechanics in detail, though any change still requires your prescriber's guidance before you adjust anything. If the query is actually about drawing a mid-strength dose from a 2.5mg pen, that is a separate conversation.

The practical check you can do right now: look at the label on your pen. The strength is printed clearly. If it reads 5mg/dose, each injection is 5mg. If you expected a different strength, contact your pharmacy before injecting. It takes under a minute and removes any doubt.

The Mounjaro SmPC on the eMC makes this plain: the licensed starting dose is 2.5mg, titrated in 2.5mg steps by the prescriber, typically every four weeks. 3.75mg does not appear anywhere in that schedule.

What 3.75mg of Mounjaro in ml would actually be, and why the number is academic

People sometimes ask how many ml is 3.75mg of Mounjaro from a 5mg pen, usually because they are trying to cross-check what they received or calculate a partial draw. For reference: the 5mg pen contains a total of 0.5ml of solution across four doses (each dose therefore being 0.125ml). A 3.75mg amount would theoretically be 0.09375ml, a volume so small it could not be measured or drawn accurately with any standard device, let alone a KwikPen.

This is not a pedantic point. Precision with insulin-class devices matters. Even experienced nurses working with conventional syringes accept measurement error in tiny volumes. A pre-filled auto-injector removes that risk by delivering an exact, validated dose every time. Trying to extract a non-standard volume undermines the entire point of the device.

If you are currently on the 5mg dose and feel it is too much (side effects are troublesome, or you want a slower increase) the correct route is to speak to your prescriber. They may extend the time at your current dose, explore whether a different strength pen is appropriate, or review whether Mounjaro is the right fit. You can read more about the 5mg Mounjaro pen and what the dose involves before that conversation.

The licensed dose steps and why the gaps exist

Mounjaro's titration schedule (2.5, 5, 7.5, 10, 12.5, 15mg) was designed around the tolerability data from the SURMOUNT clinical programme, which enrolled thousands of adults across multiple trials. The gaps between steps reflect how long most people need to adjust to each level before moving up. Stepping from 2.5mg to 5mg is the first increase; 3.75mg was never tested as a standalone dose.

This matters because prescribers authorise a specific strength for a reason. The NHS patient information for tirzepatide, published by NHS England, is clear that dose changes should follow the prescriber's guidance and the instructions in the leaflet. Going below or above what is written (even with the best intentions) can affect how the medicine works and make side effects harder to interpret.

If a dose feels wrong in either direction, a prescriber can adjust. That is precisely what clinical oversight is for. Our guidance on missed or late doses covers another common situation where readers are tempted to self-adjust; the principle is the same: the leaflet and your prescriber are the authority, not a formula you calculate at home.

When the 3.75mg question points to a real underlying concern

Sometimes this search comes from a genuine problem: side effects that feel unmanageable, a dose that seems too strong, or uncertainty about whether you are on the right pen. Those are legitimate concerns that deserve a proper answer, not a workaround.

If you are experiencing significant nausea, vomiting or other GI symptoms after a dose increase, the right step is to flag it to whoever is overseeing your treatment. At nume, our prescribers are available seven days a week for aftercare queries, a message to our team gets a clinical response, not a chatbot. Side effects after a dose change often settle within two weeks, but if they are severe or persistent, that needs clinical eyes.

For anyone not yet on treatment who is weighing up the programme, our full Mounjaro overview covers the evidence, the titration schedule and who the medicine is licensed for. The question of which dose suits you is answered during the consultation, not before it. If you are ready to have that conversation, speaking to our prescribers is the place to start.